Replies to post #3637 on Axim Biotechnologies Inc (AXIM)

[janeyH]

From the S1

Subject to the terms and conditions of the Equity Purchase Agreement, we have the right to “put,” or sell, up to $30,000,000 worth of shares of our common stock to Cross.

read it

[Devolution]

Let's make this point very clear: Cross and Company has AGREED to buy as much as 26.5 million shares up to a maximum value of $30 million.

Doing the math, that would be a maximum pps of $1.13 per share.

Of course, AXIM might sell less shares to get to the $30 million, which would put the pps at above $1.13 per share, or AXIM could sell all the shares for much less than $1.13 per share and not max out ($30 million) on that line of "credit" (it is actually a financing deal).

My thoughts here are the following: This is a future deal, to be acted upon at some date in the future, just being prepped so that it can be taken advantage of at the most opportune time. (at the drop of a dime?) The parameters, agreed to by both companies (the financier, Cross, and the recipient of the financing, AXIM), are very ambitious, putting the stock valuation possibly over $1 per share.

The agreement allows Cross to immediately sell the shares, so no doubt the financing will occur at the going rate on the day it is executed.

Keep in mind this is essentially a line of financing, which suggests it is ongoing and can be done in pieces rather than all at once.

It would appear that this agreement might be preparing for something big on the horizon.

Perhaps AXIM will soon be making the move we have all been anxiously waiting for.